{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:52:49Z","timestamp":1785883969096,"version":"3.56.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003990","name":"Conseil R\u00e9gional, \u00cele-de-France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008487","name":"Finnish Government Ministry of Social Affairs and Health","doi-asserted-by":"publisher","award":["TYH2024310"],"award-info":[{"award-number":["TYH2024310"]}],"id":[{"id":"10.13039\/501100008487","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rpth.2026.106790","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T01:11:17Z","timestamp":1781313077000},"page":"106790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Von Willebrand disease: A century of progress"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8271-6795","authenticated-orcid":false,"given":"Caterina","family":"Casari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Susen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Lassila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106790_bib1","first-page":"87","article-title":"Hereditar pseudohemophili","volume":"68","author":"von Willebrand","year":"1926","journal-title":"Finska Lakaresallskapets Handlinger"},{"key":"10.1016\/j.rpth.2026.106790_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/hae.12243","article-title":"Erik von Willebrand","volume":"19","author":"Lassila","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106790_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1126\/science.7352265","article-title":"Red blood cells: their dual role in thrombus formation","volume":"207","author":"Turitto","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.rpth.2026.106790_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3324\/haematol.2024.286012","article-title":"The landmark contribution by Erik von Willebrand","volume":"111","author":"Lassila","year":"2026","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106790_bib5","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib6","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib7","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106790_bib8","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib9","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1182\/blood.2023023277","article-title":"How unique structural adaptations support and coordinate the complex function of von Willebrand factor","volume":"144","author":"Lenting","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib10","doi-asserted-by":"crossref","first-page":"9985","DOI":"10.1074\/jbc.M006548200","article-title":"Identification of the collagen-binding site of the von Willebrand factor A3-domain","volume":"276","author":"Romijn","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2026.106790_bib11","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0969-2126(97)00266-9","article-title":"Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding","volume":"5","author":"Huizinga","year":"1997","journal-title":"Structure"},{"key":"10.1016\/j.rpth.2026.106790_bib12","doi-asserted-by":"crossref","first-page":"16279","DOI":"10.1074\/jbc.C700241200","article-title":"Redundant mechanism of platelet adhesion to laminin and collagen under flow: involvement of von Willebrand factor and glycoprotein Ib-IX-V","volume":"283","author":"Inoue","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2026.106790_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12534","article-title":"Fibronectin binding to von Willebrand factor occurs via the A1 domain","volume":"5","author":"Keesler","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib14","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1038\/s41467-021-22634-x","article-title":"Activation of von Willebrand factor via mechanical unfolding of its discontinuous autoinhibitory module","volume":"12","author":"Arce","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.rpth.2026.106790_bib15","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1021\/bi020044f","article-title":"Two clusters of charged residues located in the electropositive face of the von Willebrand factor A1 domain are essential for heparin binding","volume":"41","author":"Rastegar-Lari","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.rpth.2026.106790_bib16","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.2019000510","article-title":"The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing","volume":"133","author":"Ishihara","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib17","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2014-08-595686","article-title":"von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans","volume":"125","author":"Bauer","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI110946","article-title":"Platelets have more than one binding site for von Willebrand factor","volume":"72","author":"Ruggeri","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2026.106790_bib19","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/S0021-9258(19)50746-3","article-title":"Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis","volume":"267","author":"Beacham","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2026.106790_bib20","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-019-11474-5","article-title":"Crystal structure and substrate-induced activation of ADAMTS13","volume":"10","author":"Petri","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.rpth.2026.106790_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jth.15247","article-title":"Von Willebrand disease type 2N: an update","volume":"19","author":"Seidizadeh","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2516.1998.440665.x","article-title":"Females with von Willebrand disease: 72 years as the silent majority","volume":"4","author":"Kouides","year":"1998","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106790_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/hae.12898","article-title":"Von Willebrand factor for menorrhagia: a survey and literature review","volume":"22","author":"Ragni","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106790_bib24","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients","volume":"10","author":"Castaman","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib25","first-page":"588","article-title":"von Willebrand disease and angiodysplasia: a wider view of pathogenesis in pursuit of therapy","volume":"110","author":"Crossette-Thambiah","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106790_bib26","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/hae.15034","article-title":"Retrospective chart review of GI bleeding in people with von Willebrand disease","volume":"30","author":"Roberts","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106790_bib27","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.jtha.2024.06.020","article-title":"Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs","volume":"22","author":"Daniel","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3324\/haematol.2024.286059","article-title":"Gynecologic and obstetric management of girls and women with von Willebrand disease","volume":"111","author":"Abdul-Kadir","year":"2026","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106790_bib29","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jtha.2022.11.045","article-title":"Variability in International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance","volume":"21","author":"Doherty","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib30","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1182\/blood.2020008501","article-title":"von Willebrand disease: what does the future hold?","volume":"137","author":"Denis","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib31","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1538-7836.2010.03864.x","article-title":"Health-related quality of life among adult patients with moderate and severe von Willebrand disease","volume":"8","author":"de Wee","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib32","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.jtha.2025.05.017","article-title":"Health-related quality of life in children with von Willebrand disease: results of the French real-life Willebrand Study Health-related Quality of Life study","volume":"23","author":"Goudemand","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib33","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1538-7836.2005.01369.x","article-title":"von Willebrand factor: two sides of a coin","volume":"3","author":"Sadler","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12185-012-1041-x","article-title":"von Willebrand factor: at the crossroads of bleeding and thrombosis","volume":"95","author":"Denis","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.rpth.2026.106790_bib35","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1016\/j.jtha.2025.06.014","article-title":"Molecular basis of thrombotic microangiopathy","volume":"23","author":"Zhou","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.blre.2014.04.003","article-title":"Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis","volume":"28","author":"Sonneveld","year":"2014","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2026.106790_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jvssci.2021.08.002","article-title":"Role of von Willebrand factor in venous thromboembolic disease","volume":"3","author":"Michels","year":"2022","journal-title":"JVS Vasc Sci"},{"key":"10.1016\/j.rpth.2026.106790_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/jth.12194","article-title":"Reduced prevalence of arterial thrombosis in von Willebrand disease","volume":"11","author":"Sanders","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib39","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/j.thromres.2012.09.005","article-title":"Thrombosis in VonWillebrand disease","volume":"130","author":"Qureshi","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106790_bib40","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jth.13142","article-title":"Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register","volume":"13","author":"Seaman","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr5250","article-title":"Role of von Willebrand factor (VWF), platelets, and aberrant flow in the initiation of venous thrombosis","volume":"11","author":"Mereweather","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib42","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/jth.12008","article-title":"von Willebrand factor: the old, the new and the unknown","volume":"10","author":"Lenting","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib43","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.2023021915","article-title":"Novel functions for von Willebrand factor","volume":"144","author":"Atiq","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib44","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/jth.14976","article-title":"Von Willebrand factor and cancer; metastasis and coagulopathies","volume":"18","author":"Patmore","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib45","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/bjh.12249","article-title":"The molecular characterization of von Willebrand disease: good in parts","volume":"161","author":"James","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.106790_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2026.106790_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease. for the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000718","article-title":"Importance of genotyping in von Willebrand disease to elucidate pathogenic mechanisms and variability in phenotype","volume":"6","author":"Atiq","year":"2022","journal-title":"Hemasphere"},{"key":"10.1016\/j.rpth.2026.106790_bib50","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-2006-947870","article-title":"Genetic testing for von Willebrand disease: the Canadian experience","volume":"32","author":"James","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106790_bib51","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/blood.2020009999","article-title":"von Willebrand factor antigen levels are associated with burden of rare nonsynonymous variants in the VWF gene","volume":"137","author":"Sadler","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib52","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/jth.14304","article-title":"Genetic regulation of plasma von Willebrand factor levels in health and disease","volume":"16","author":"Swystun","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib53","first-page":"350","article-title":"Type 2N von Willebrand disease","volume":"4","author":"Mazurier","year":"2005","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.rpth.2026.106790_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","article-title":"Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance","volume":"16","author":"Terraube","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106790_bib55","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/hae.13175","article-title":"Molecular diagnosis of von Willebrand disease","volume":"23","author":"Baronciani","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106790_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jcm6040045","article-title":"Diagnosis and treatment of von Willebrand disease and rare bleeding disorders","volume":"6","author":"Castaman","year":"2017","journal-title":"J Clin Med"},{"issue":"Suppl 4","key":"10.1016\/j.rpth.2026.106790_bib57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2516.2004.00991.x","article-title":"Clinical diagnosis of von Willebrand disease","volume":"10","author":"Federici","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106790_bib58","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood-2013-06-498303","article-title":"von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy","volume":"122","author":"Lillicrap","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib60","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib61","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/bloodadvances.2020002038","article-title":"Low VWF: insights into pathogenesis, diagnosis, and clinical management","volume":"4","author":"O\u2019Donnell","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib62","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102686","article-title":"Challenges and considerations of genetic testing in von Willebrand disease","volume":"9","author":"Seidizadeh","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib64","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib65","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/bloodadvances.2020002452","article-title":"Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause","volume":"4","author":"Mehic","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-3148.2001.00315.x","article-title":"The relationship between ABO histo-blood group, factor VIII and von Willebrand factor","volume":"11","author":"O\u2019Donnell","year":"2001","journal-title":"Transfus Med"},{"key":"10.1016\/j.rpth.2026.106790_bib67","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000112970","article-title":"Effects of cigarette smoking on hematological parameters and von Willebrand factor functional activity levels in asymptomatic male and female Arab smokers","volume":"17","author":"Al-Awadhi","year":"2008","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.rpth.2026.106790_bib69","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2013.052","article-title":"Changes of von Willebrand factor during pregnancy in women with and without von Willebrand disease","volume":"5","author":"Castaman","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.rpth.2026.106790_bib70","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jsams.2006.06.001","article-title":"Hemostatic response to acute physical exercise in healthy adolescents","volume":"10","author":"Ribeiro","year":"2007","journal-title":"J Sci Med Sport"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2026.106790_bib71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/jth.12257","article-title":"Translational medicine advances in von Willebrand disease","volume":"11","author":"Lillicrap","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2026.106790_bib72","first-page":"S4","article-title":"von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies","volume":"87","author":"James","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2026.106790_bib73","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood.2023021452","article-title":"A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels","volume":"143","author":"de Vries","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib74","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.118.034532","article-title":"Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels","volume":"139","author":"Sabater-Lleal","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2026.106790_bib75","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2026.106790_bib76","article-title":"Association of single nucleotide polymorphisms in the ST3GAL4 gene with VWF antigen and factor VIII activity","volume":"11","author":"Song","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2026.106790_bib77","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/ejhg.2016.21","article-title":"Genome-wide association studies identify genetic loci for low von Willebrand factor levels","volume":"24","author":"van Loon","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.rpth.2026.106790_bib78","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/asheducation-2009.1.106","article-title":"Low von Willebrand factor: sometimes a risk factor and sometimes a disease","volume":"2009","author":"Sadler","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2026.106790_bib79","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1538-7836.2004.00933.x","article-title":"Slippery criteria for von Willebrand disease type 1","volume":"2","author":"Sadler","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib80","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/hematology.2019000064","article-title":"New advances in the diagnosis of von Willebrand disease","volume":"2019","author":"Sharma","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2026.106790_bib81","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MBC.0b013e32834a7e01","article-title":"Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays","volume":"22","author":"Favaloro","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2026.106790_bib82","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/978-1-4939-7196-1_33","article-title":"Laboratory testing for von Willebrand factor activity by glycoprotein Ib binding assays (VWF:GPIb)","volume":"1646","author":"Patzke","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2026.106790_bib83","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib84","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib85","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1016\/j.jtha.2024.08.015","article-title":"Low von Willebrand factor\u2014unraveling an enigma wrapped in a conundrum","volume":"22","author":"O\u2019Donnell","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib86","doi-asserted-by":"crossref","first-page":"e908","DOI":"10.1016\/S2352-3026(25)00262-5","article-title":"Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implications","volume":"12","author":"Seidizadeh","year":"2025","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2026.106790_bib87","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jtha.2025.07.013","article-title":"A phase 1, open-label study to assess the pharmacokinetics, safety, and tolerability of a single intravenous injection of efanesoctocog alfa in adults with type 2N or type 3 von Willebrand disease","volume":"24","author":"Susen","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib89","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-0044-1787662","article-title":"Emicizumab in type 3 von Willebrand disease: report of a case with an alloantibody and literature review","volume":"51","author":"Giuffrida","year":"2025","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106790_bib90","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood.2025029401","article-title":"A bispecific nanobody for the treatment of von Willebrand disease type 1","volume":"146","author":"Peyron","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106790_bib91","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1182\/bloodadvances.2025018516","article-title":"HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease","volume":"10","author":"H\u00e4ger","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib92","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1182\/bloodadvances.2022007805","article-title":"The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF\/FVIII in type 2B von Willebrand disease","volume":"6","author":"Ay","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib93","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3324\/haematol.2024.286037","article-title":"Historical, current and future treatments for von Willebrand disease","volume":"111","author":"Casari","year":"2026","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106790_bib94","first-page":"1710","article-title":"Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A","volume":"110","author":"Gringeri","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106790_bib95","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1055\/s-0037-1614080","article-title":"The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients","volume":"84","author":"Keularts","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib96","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/bloodadvances.2025016487","article-title":"Treatment of von Willebrand disease","volume":"10","author":"Connell","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib97","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jtha.2023.01.001","article-title":"von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS","volume":"21","author":"Pagliari","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106790_bib98","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/bloodadvances.2020003891","article-title":"Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease","volume":"5","author":"Bukkems","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/bloodadvances.2021005666","article-title":"Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature","volume":"6","author":"Brignardello-Petersen","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib100","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/bloodadvances.2025016486","article-title":"The interplay of von Willebrand disease and women\u2019s reproductive health","volume":"10","author":"Langer","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106790_bib101","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1016\/S2352-3026(23)00165-5","article-title":"Heavy menstrual blood loss in patients with von Willebrand disease: an unsolved problem","volume":"10","author":"Leebeek","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2026.106790_bib102","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/hae.15122","article-title":"A core outcome set for prophylaxis and perioperative treatment of von Willebrand disease: the coreVWD initiative","volume":"30","author":"Clearfield","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106790_bib103","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926034485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926034485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:30:24Z","timestamp":1785882624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926034485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2475037926034485"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106790","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Von Willebrand disease: A century of progress","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106790"}}